Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

NCT03682302 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain Management

Interventions

DRUG: Exparel
DRUG: 0.5% Bupivacaine HCl

Sponsor

Pacira Pharmaceuticals, Inc